By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Crown Bioscience, Inc. 

4008 Burton Drive

Santa Clara  California  95054  U.S.A.
Phone: 617-818-2285 Fax: 408-986-0019


SEARCH JOBS
Crown Bioscience, Inc. is a premium biology CRO, providing discovery and early development solutions for global biotech and pharmaceutical companies. It is headquartered in the Silicon Valley, with wholly owned research centers in Beijing, China and Indianapolis. Crown Bioscience is the leader in providing high-quality and cost-effective services in preclinical oncology. Our services include target protein expression, purification and crystallization, in vitro/in vivo pharmacology, non-GLP toxicology, PK/PD, and translational research with patient-derived cell lines and animal models.

For more information, please visit our web site at www.crownbio.com.


Key Statistics


Email: apandey@crownbio.com
Ownership: Private

Web Site: Crown Bioscience, Inc.
Employees:
Symbol: 
 



Industry
Pharmaceutical

Segment
Oncology





Company News
Crown Bioscience, Inc. Strengthens Pre-Clinical Leadership Team With Senior Appointment 1/28/2015 9:22:20 AM
Crown Bioscience, Inc. Announces First European Symposium On Translational Oncology And The Use Of Patient-Derived Xenograft Models For Oncology Drug Discovery And Human Surrogate Trials 1/14/2015 11:16:45 AM
Crown Bioscience, Inc. Expands Operations And Re-Brands UK Site 1/8/2015 11:01:38 AM
Crown Bioscience, Inc. Release: Crown Bioscience Service Center Opening At David H. Murdock Research Institute 10/22/2014 11:13:36 AM
Crown Bioscience, Inc. Service Center Opening At David H. Murdock Research Institute 10/21/2014 10:28:00 AM
Crown Bioscience, Inc. Announces Inaugural Symposium To Foster Greater Understanding Of Predictive Models In Oncology 8/14/2014 2:24:21 PM
Crown Bioscience, Inc. President Dr. Jean-Pierre Wery Honored In PharmaVOICE 100 8/1/2014 2:42:42 PM
Crown Bioscience, Inc. Reveals Strategy For Combining Drug Therapy With Irradiation to Overcome Resistance To Oncology Therapeutics 6/19/2014 9:16:28 AM
Crown Bioscience, Inc. To Showcase Progression In Human Surrogate Trials At The 50th American Society of Clinical Oncology Annual Meeting 5/30/2014 9:46:51 AM
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014 8:55:04 AM
123
//-->